2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5

Description:

Nomen: 2,3,5-Tri-O-benzyl-D-ribonolactone

Synonyma: 2,3,5-Tri-O-Benzyl-D-Ribono-1,4-Lactone

CAS: 55094-52-5

Aspectus: Alba ad fere alba pulveris

Puritas: ≥99.0%

Medium Remdesiviri (CAS 1809249-37-3) COVID-19

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum 2,3,5-Tri-O-benzyl-D-ribonolactone
Synonyma 2,3,5-Tri-O-Benzyl-D-Ribono-1,4-Lactone;Remdesivir medium
CAS Number 55094-52-5
CATTUS Number RF-PI301
Stock Status In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae C26H26O5
M. Pondus 418.49
Liquescens punctum 54.0-55.0℃
Repono Condition Locus temperatus
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Flavo vel albo solidus
Solubilitas Solutum in CH2Cl2 et insolubile in H2O
NMR et Ms Si parere
Lepidium sativum IR et TLC
umor ≤1.0%
Residere in Ignition ≤0.50%
Omnis immunditia ≤0.50%
Metalla gravis ≤50ppm
HPLC (210nm) ≥99.0%
HPLC (ELSD) ≥99.0%
Test Standard Enterprise Standard
Consuetudinem Intermedia Remdesiviri (CAS 1809249-37-3)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

1

FAQ:

Applicatio:

2.3,5-Tri-O-benzyl-D-ribonolactone (CAS 55094-52-5) est Remdesivir medium.Remdesivir (CAS 1809249-37-3) est medicamentum novum antivirale in genere analogorum nucleotidis, adhibitum in curatione COVID-19.Remdesivir (GS-5734) nova est analogi nuclei antiviralis quae vetat virus hepatitis murinum (MHV) cum similibus EC50 sicut SARS-CoV et MERS-CoV.Coronavirus (CoVs) sunt sensus positive, RNA virus solitarii qui amplis exercitibus animalium inficiunt.In hominibus, CoVs tamquam frigora et pneumonia typice causantes agnita sunt usquedum ad emergentem gravium respiratorii acuta syndrome coronavirus (SARS-CoV) in Medio Oriente 2002 et syndrome respiratorii coronavirus (MERS-CoV) in MMXII e fontibus zoonoticis.Remdesivir monophosphoramidata prodrug C-adenosini nucleosidi analogi GS-441524 est.In tumore cerebri morato (DBT) cellulis MHV, GS-5734 infectis potentius inhibuit MHV quam GS-441524, cum GS-5734 EC50 de 0.03 M. Praeterea valores EC50 post curationem cum GS-441524 et GS-5734 determinati sunt. in SARS-CoV- et MERS-CoV pestilentiae culturas primas humanas airway epithelial (HAE) .

Epistulam tuam hic scribe et mitte nobis